Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Ingre

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Nature Communications|November 8, 2022
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progressionSolmaz Yazdani, Christina Seitz, Can Cui, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2020
TRICALS: creating a highway toward a cureRuben P A van Eijk, Tessa Kliest, Christopher J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2023
<i>UNC13A</i> in amyotrophic lateral sclerosis: from genetic association to therapeutic targetSean W Willemse, Peter Harley, Ruben P A van Eijk, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 24, 2023
PRECISION ALS-an integrated pan European patient data platform for ALSRobert McFarlane, Miriam Galvin, Mark Heverin, et al.
Trials|December 5, 2022
Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trialSean W Willemse, Kit C B Roes, Philip Van Damme, et al.
Journal of Neurology|December 12, 2024
Diagnosing primary lateral sclerosis: a clinico-pathological studyEva M J de Boer, Bálint S de Vries, Wim Van Hecke, et al.
JAMA Neurology|March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical TrialJeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALSHarry McDonough, Robert McFarlane, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS studyStefan Sennfält, Ammar Al-Chalabi, Alejandro Caravaca Puchades, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Nature Communications|November 8, 2022
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progressionSolmaz Yazdani, Christina Seitz, Can Cui, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 10, 2020
TRICALS: creating a highway toward a cureRuben P A van Eijk, Tessa Kliest, Christopher J McDermott, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|March 17, 2026
ALS motor phenotypes: a revised 'OPM' classificationThomas Meyer, Nicola Ticozzi, Markus Weber, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 3, 2023
<i>UNC13A</i> in amyotrophic lateral sclerosis: from genetic association to therapeutic targetSean W Willemse, Peter Harley, Ruben P A van Eijk, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 24, 2023
PRECISION ALS-an integrated pan European patient data platform for ALSRobert McFarlane, Miriam Galvin, Mark Heverin, et al.
Trials|December 5, 2022
Lithium carbonate in amyotrophic lateral sclerosis patients homozygous for the C-allele at SNP rs12608932 in UNC13A: protocol for a confirmatory, randomized, group-sequential, event-driven, double-blind, placebo-controlled trialSean W Willemse, Kit C B Roes, Philip Van Damme, et al.
Journal of Neurology|December 12, 2024
Diagnosing primary lateral sclerosis: a clinico-pathological studyEva M J de Boer, Bálint S de Vries, Wim Van Hecke, et al.
JAMA Neurology|March 24, 2025
Reldesemtiv in Amyotrophic Lateral Sclerosis: Results From the COURAGE-ALS Randomized Clinical TrialJeremy M Shefner, Merit E Cudkowicz, Angela Genge, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Examining changing working status and caregiver assistance in amyotrophic lateral sclerosis (ALS) using large-scale European databases as part of PRECISION-ALSHarry McDonough, Robert McFarlane, Alejandro Caravaca Puchades, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 6, 2025
Respiratory function, survival, and NIV prevalence over time in ALS - a PRECISION ALS studyStefan Sennfält, Ammar Al-Chalabi, Alejandro Caravaca Puchades, et al.
Pageof 9